A clear trend of decreased incidences in headache and lymphopenia were observed from year 1 to year 14.
← all excerpts
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results.
1
—
—
A clear trend of decreased incidences in headache and lymphopenia were observed from year 1 to year 14.